Sally Beauty Holdings, Inc. filings document formal disclosures for a NYSE-listed professional beauty-products retailer with common stock traded under the symbol SBH. Recent Form 8-K reports cover quarterly operating results, Regulation FD updates, strategy and business outlook commentary, earnings-release exhibits, and capital-allocation details such as debt repayment and share repurchases.
The company’s governance filings include Item 5.02 reports on executive and director changes, related compensatory arrangements, and board composition. Proxy and annual meeting records document director elections, advisory votes on executive compensation, auditor ratification, stockholder voting results, and executive compensation disclosures.
Sally Beauty Holdings director Erin Nealy Cox received a new equity award in the form of restricted stock units (RSUs). On January 22, 2026, she was granted 9,975 RSUs at a price of $0 per unit, reported as a derivative security.
The RSUs convert into Sally Beauty common stock on a one-for-one basis, meaning each unit represents one share when settled. According to the disclosure, 100% of the RSUs vest when her service as a director ends. After this grant, she beneficially owns 9,975 derivative securities directly.
James M. Head, a director of Sally Beauty Holdings, Inc. (SBH), received 9,975 restricted stock units (RSUs) on 01/22/2026. The RSUs were acquired at a price of $0 per unit and are held directly. Each RSU converts into one share of SBH common stock, so this grant represents 9,975 underlying shares of common stock. According to the terms, 100% of the RSUs vest when Mr. Head’s service as a director has terminated, meaning he must remain on the board until his service ends to receive the full benefit of this equity award.
Sally Beauty Holdings director Rachel Rothe Bishop reported equity-based compensation and a related share conversion. On 01/22/2026, she received 9,975 restricted stock units (RSUs), which each convert into one share of SBH common stock. All of these RSUs are scheduled to vest on the earlier of 01/22/2027 or the company’s next annual meeting of stockholders. The same day, 14,532 RSUs were converted into 14,532 shares of common stock at a stated price of $0 per share, increasing her directly held common stock to 36,231 shares.
Sally Beauty Holdings director Jeffrey N. Boyer reported equity transactions dated 01/22/2026. He acquired 9,975 restricted stock units (RSUs) at an exercise price of $0, which will vest in full on the earlier of 01/22/2027 or the company’s next annual meeting of stockholders. RSUs convert into Sally Beauty common stock on a one-for-one basis.
On the same date, Boyer also exercised 14,532 RSUs at $0 per share, receiving 14,532 shares of common stock. Following these transactions, he directly holds 42,460 shares of common stock and 9,975 RSUs.
Sally Beauty Holdings director Dorlisa K. Flur reported equity-based compensation activity involving company stock. On 01/22/2026, 14,532 Restricted Stock Units were exercised at $0 into 14,532 shares of common stock, increasing her directly held common shares to 57,138 after the transaction. The same day, she received a new grant of 9,975 Restricted Stock Units at $0, each convertible into one share of Sally Beauty common stock.
All 9,975 new RSUs are scheduled to vest on the earlier of 01/22/2027 or the date of Sally Beauty’s next Annual Meeting of Stockholders. These transactions reflect routine director compensation and equity vesting rather than open-market buying or selling.
Sally Beauty Holdings director Molloy Lawrence reported equity compensation activity involving restricted stock units (RSUs) and common stock. On January 22, 2026, Lawrence acquired 9,975 RSUs at an exercise price of $0. These RSUs convert into Sally Beauty Holdings common stock on a one-for-one basis and are scheduled to vest in full when Lawrence’s service as a director ends.
On the same date, Lawrence exercised RSUs covering 14,532 shares, converting them into an equal number of common shares at a price of $0. Following this settlement, Lawrence directly owned 30,002 shares of common stock, reflecting updated direct beneficial ownership after the reported transactions.
Sally Beauty Holdings director Diana Sue Ferguson received an equity award in the form of restricted stock units (RSUs). On January 22, 2026, she was granted 9,975 RSUs at a price of $0 per unit, held as a direct ownership position. Each RSU converts into one share of Sally Beauty common stock.
The filing states that 100% of these RSUs vest on the earliest of three events: December 31, 2036, the date her service as a director ends, or a change in control of the company. After this transaction, she beneficially owns 9,975 derivative securities related to common stock through this RSU grant.
Sally Beauty Holdings, Inc. reported the results of its 2026 Annual Meeting of Stockholders. There were 98,266,491 shares of common stock entitled to vote, and 89,239,188 shares were represented in person or by proxy, establishing a quorum.
Stockholders elected ten directors to serve until the 2027 annual meeting or until their successors are elected and qualified. Each nominee, including Board Chair Diana S. Ferguson and President and CEO Denise Paulonis, received substantially more votes "for" than "against," with additional broker non-votes reported.
On an advisory basis, stockholders approved the compensation of the company’s named executive officers, with 75,355,571 votes for, 9,292,917 against, and 238,768 abstentions, plus broker non-votes. Stockholders also ratified the appointment of KPMG LLP as the independent registered public accounting firm for the 2026 fiscal year, with 86,845,312 votes for, 2,383,449 against, and 10,427 abstentions.
Sally Beauty Holdings, Inc. reported an insider share sale by one of its senior executives. The reporting person, an officer serving as GVP, Controller & CAO, sold 5,900 shares of Sally Beauty common stock on 12/11/2025. The sale was coded as an open-market sale and was executed at a weighted average price of $15.7116 per share, with individual trade prices ranging from $15.655 to $15.79.
After this transaction, the officer continued to beneficially own 21,295 shares of Sally Beauty common stock, held directly. The trades were executed through a broker-dealer using multiple same-way open-market orders, and the officer undertook to provide detailed price breakdowns upon request to regulators, the company, or shareholders.
Sally Beauty Holdings, Inc. filed a notice that a shareholder plans to sell shares under Rule 144. The filing covers a proposed sale of 5,900 shares of common stock through UBS Financial Services Inc. on or about 12/11/2025, with an indicated aggregate market value of 92,925. The company had 97,497,664 shares of common stock outstanding at the time referenced in the notice.
The shares to be sold were acquired on 11/15/2024 through restricted stock vesting from Sally Beauty Holdings, Inc., with payment described as cash. The person signing the notice represents that they are not aware of any undisclosed material adverse information about the company’s current or prospective operations.